Literature DB >> 15100308

Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta.

Khaldun Al-Khatib1, Bryan R G Williams, Robert H Silverman, William Halford, Daniel J J Carr.   

Abstract

To evaluate the anti-HSV-1 mechanisms of murine IFN-beta in ocular infection, mice were transduced with an adenoviral vector expressing murine IFN-beta (Ad:IFN-beta). Ocular transduction with Ad:IFN-beta resulted in enhanced survival following infection with HSV-1. The protective effect was associated with a reduction in 1) viral titer, 2) viral gene expression, 3) IFN-gamma levels, and 4) the percentage of CD8(+) T lymphocyte and NK cell infiltration in infected tissue. Expression of IFN-beta resulted in an elevation of the IFN-induced antiviral gene 2',5'-oligoadenylate synthetase (OAS1a) but not dsRNA-dependent protein kinase R (PKR) in the cornea and trigeminal ganglion (TG). Mice deficient in the downstream effector molecule of the OAS pathway, RNase L, were no more sensitive to ocular HSV-1 compared with wild-type controls in the TG based on measurements of viral titer. However, the efficacy of Ad:IFN-beta was transiently lost in the eyes of RNase L mice. By comparison, PKR-deficient mice were more susceptible to ocular HSV-1 infection, and the antiviral efficacy following transduction with Ad:IFN-beta was significantly diminished in the eye and TG. These results suggest that PKR is central in controlling ocular HSV-1 infection in the absence of exogenous IFN, whereas the OAS pathway appears to respond to exogenous IFN, contributing to the establishment of an antiviral environment in a tissue-restricted manner.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100308      PMCID: PMC4060620          DOI: 10.4049/jimmunol.172.9.5638

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  63 in total

1.  Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways.

Authors:  A Zhou; J M Paranjape; S D Der; B R Williams; R H Silverman
Journal:  Virology       Date:  1999-06-05       Impact factor: 3.616

2.  Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.

Authors:  H Cheng; T M Tumpey; H F Staats; N van Rooijen; J E Oakes; R N Lausch
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-05       Impact factor: 4.799

3.  Interferon-beta directly influences monocyte infiltration into the central nervous system.

Authors:  Sarah Floris; Sigrid R Ruuls; Anne Wierinckx; Susanne M A van der Pol; Ed Döpp; Peter H van der Meide; Christine D Dijkstra; Helga E De Vries
Journal:  J Neuroimmunol       Date:  2002-06       Impact factor: 3.478

4.  Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

Authors:  Maria Montoya; Giovanna Schiavoni; Fabrizio Mattei; Ion Gresser; Filippo Belardelli; Persephone Borrow; David F Tough
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

5.  Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR.

Authors:  N Abraham; D F Stojdl; P I Duncan; N Méthot; T Ishii; M Dubé; B C Vanderhyden; H L Atkins; D A Gray; M W McBurney; A E Koromilas; E G Brown; N Sonenberg; J C Bell
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

6.  Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-alpha and -gamma.

Authors:  M J Balish; M E Abrams; A M Pumfery; C R Brandt
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

7.  Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection.

Authors:  T Liu; Q Tang; R L Hendricks
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

8.  The antiviral efficacy of the murine alpha-1 interferon transgene against ocular herpes simplex virus type 1 requires the presence of CD4(+), alpha/beta T-cell receptor-positive T lymphocytes with the capacity to produce gamma interferon.

Authors:  Daniel J J Carr; Sansanee Noisakran
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1.

Authors:  C Shimeld; J L Whiteland; S M Nicholls; E Grinfeld; D L Easty; H Gao; T J Hill
Journal:  J Neuroimmunol       Date:  1995-08       Impact factor: 3.478

10.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  8 in total

1.  Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea.

Authors:  Bobbie Ann Austin; William P Halford; Bryan R G Williams; Daniel J J Carr
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

2.  Herpes simplex virus type 2-mediated disease is reduced in mice lacking RNase L.

Authors:  Rebecca J Duerst; Lynda A Morrison
Journal:  Virology       Date:  2006-12-06       Impact factor: 3.616

3.  Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways.

Authors:  Daniel J J Carr; Bobbie A Austin; William P Halford; Patrick M Stuart
Journal:  J Neuroimmunol       Date:  2008-11-29       Impact factor: 3.478

4.  Innate and adaptive immune responses to herpes simplex virus.

Authors:  Tracy Chew; Kathryne E Taylor; Karen L Mossman
Journal:  Viruses       Date:  2009-11-18       Impact factor: 5.048

5.  Resistance to HSV-1 infection in the epithelium resides with the novel innate sensor, IFI-16.

Authors:  C D Conrady; M Zheng; K A Fitzgerald; C Liu; D J J Carr
Journal:  Mucosal Immunol       Date:  2012-01-11       Impact factor: 7.313

Review 6.  Macrophages and cytokines in the early defence against herpes simplex virus.

Authors:  Svend Ellermann-Eriksen
Journal:  Virol J       Date:  2005-08-03       Impact factor: 4.099

7.  Noncognate Signals Drive Enhanced Effector CD8+ T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0ΔNLS, against Herpes Simplex Virus 1.

Authors:  Grzegorz B Gmyrek; Paul Predki; Edward Gershburg; Daniel J J Carr
Journal:  J Virol       Date:  2022-01-19       Impact factor: 6.549

Review 8.  Herpes Simplex Virus Evasion of Early Host Antiviral Responses.

Authors:  Eduardo I Tognarelli; Tomás F Palomino; Nicolás Corrales; Susan M Bueno; Alexis M Kalergis; Pablo A González
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.